Are you over 18 and want to see adult content?
More Annotations
A complete backup of https://darkermagazine.ru
Are you over 18 and want to see adult content?
A complete backup of https://practicaltravelgear.com
Are you over 18 and want to see adult content?
A complete backup of https://frenzalrhomb.com.au
Are you over 18 and want to see adult content?
A complete backup of https://martins-supermarkets.com
Are you over 18 and want to see adult content?
A complete backup of https://moscow-faq.ru
Are you over 18 and want to see adult content?
A complete backup of https://envisionrx.com
Are you over 18 and want to see adult content?
A complete backup of https://primeventures.com
Are you over 18 and want to see adult content?
A complete backup of https://ctcd.edu
Are you over 18 and want to see adult content?
A complete backup of https://catacombedinapoli.it
Are you over 18 and want to see adult content?
A complete backup of https://wonkhe.com
Are you over 18 and want to see adult content?
A complete backup of https://yaypay.com
Are you over 18 and want to see adult content?
A complete backup of https://bloggum.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of funwearsports.com
Are you over 18 and want to see adult content?
A complete backup of smithcaldwell.com
Are you over 18 and want to see adult content?
A complete backup of fustellefantasia.it
Are you over 18 and want to see adult content?
A complete backup of directoriocubano.info
Are you over 18 and want to see adult content?
Text
spread of cancer.
CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
COVID-19 GENOMICS UK CONSORTIUM: SEQUENCING COVID-19 The COVID-19 Genomics UK Consortium (COG-UK) was launched in April 2020, with the aim of sequencing the genome of the COVID-19 virus and its variants and providing data to track and analyse viral transmission within the UK. HEQ speaks with COG MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition 2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. A new study, carried out by researchers at MIT ‘s Department of Mechanical Engineering, has suggested that coronaviruses may be vulnerable toultrasound
PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections. Immunocompromised patients with HSV often have a chronic form of the virus which is resistant to any anti-viral medication, including acyclovir. CAR T-CELL THERAPIES IN EUROPE Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union. In June, the European Medicines Agency (EMA) – the EU agency responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union – recommended that marketing authorisation be granted for the first two chimeric antigen STUDY DEMONSTRATES LONG-LASTING EFFICACY OF COVID-19 Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks. Biotechnology company Defence Therapeutics Inc specialises in the development of ADCs and therapeutics for cancer and infectious diseases. The organisation BLOOD OXYGEN LEVELS COULD EXPLAIN MEMORY LOSS IN ALZHEIMER The results of a world-first study that recorded blood oxygen levels could explain why memory loss is a symptom of Alzheimer’s disease. Scientists from the University of Sussex have provided experimental proof for why the area, commonly referred to as ‘the brain’s memory centre’, is vulnerable to damage and degeneration, a precursor to Alzheimer’s disease. CUTTING THE FUEL SUPPLY TO CELLS CAN PREVENT CANCER SPREADING Halting the energy supply to certain cells can help to stop the spread of cancer, researchers have discovered. A study by scientists from the Translational Medicine Laboratory at the University of Salford has discovered that cancer spreading cells are the ‘fittest’ and therefore cutting off their fuel supply can effectively prevent thespread of cancer.
CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
COVID-19 GENOMICS UK CONSORTIUM: SEQUENCING COVID-19 The COVID-19 Genomics UK Consortium (COG-UK) was launched in April 2020, with the aim of sequencing the genome of the COVID-19 virus and its variants and providing data to track and analyse viral transmission within the UK. HEQ speaks with COG MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition 2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. A new study, carried out by researchers at MIT ‘s Department of Mechanical Engineering, has suggested that coronaviruses may be vulnerable toultrasound
PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections. Immunocompromised patients with HSV often have a chronic form of the virus which is resistant to any anti-viral medication, including acyclovir. CAR T-CELL THERAPIES IN EUROPE Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union. In June, the European Medicines Agency (EMA) – the EU agency responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union – recommended that marketing authorisation be granted for the first two chimeric antigen EU HEALTHCARE & SOCIAL CARE NEWS Health Europa brings you up to the minute news and developments from across the EU Healthcare & Social Care News sector and European (EU) health policy including the latest innovations in health research technology, pharmaceutical news, research into HOW HAS COVID-19 IMPACTED CHILD MENTAL HEALTH? 21 hours ago · Childline Service Head Alex Gray discusses the mental health struggles among children and young people during the COVID-19 pandemic. According to NHS estimates, around one in six children between the ages of five and 16 across the UK may now be suffering from issues with their mental health, up TOWARDS A UK CANNABIS INDUSTRY 1 day ago · Health Europa Quarterly (HEQ) speaks with Mike Barnes of Maple Tree Consultants and Ricardo Geada of Mackrell Solicitors about the need for a legal cannabis and CBD market in the UK. In April 2021, the UK’s Maple Tree Consultants and Mackrell Solicitors produced a collaborative discussion paper on the UK’s medical cannabis policy landscape, issuing 10 key recommendations for EUROPEAN CIVIC PRIZE ON CHRONIC PAIN: COLLECTING GOOD 1 day ago · Active Citizenship Network (ACN) is holding the ‘Patients’ right to avoid pain: reducing the burden of COVID-19, promoting best practices across EU’ event this month. The event, held by Active Citizenship Network’s (ACN), aims to feed the debate of the Conference for the Future of Europe and CANNABIS EXPORTS LICENCE APPLICATIONS OPENED BY ISLE OF 1 day ago · The Isle of Man Government has now opened licence applications for the production, distribution, and export of medical cannabis from the Island, expecting the sector to be a key contributor to the Island’s post-COVID economic recovery. The Isle of HIV TRANSMISSION IN ENGLAND COULD BE ELIMINATED BY 2030 1 day ago · The number of new HIV infections has fallen significantly in England and the country is on track to achieve elimination of transmission by 2030, new research suggests. Work by researchers from MRC Biostatistics Unit at the University of Cambridge and Public Health England (PHE) revealed that the AI-BASED TOOL COULD IMPROVE PANCREATIC CANCER RESEARCH AND 22 hours ago · A new artificial-intelligence-based tool has been developed to predict genomic subtypes of pancreatic cancer. The innovation is a collaboration between AP-HP Greater Paris University Hospitals and Owkin, a start-up pioneering federated learning and Artificial Intelligence (AI) technologies for medical research and clinical development. The tool, which is a trained and validated AImodel, can
THE RISKS AND PREVENTION OF CHOKING IN CHILDREN 1 day ago · Ian Evans of the Child Accident Prevention Trust highlights common choking hazards for infants and young children. Choking is one of the leading causes of accidental death among the under-fives in England 1.As we get older, eating, chewing, and swallowing become second nature, but it is easy to forget that these are among the first basic functions and life skills that have to belearnt.
DEFENCE THERAPEUTICS VACCINE AGAINST CANCER MAKES PROGRESS 22 hours ago · Defence Therapeutics has recently reported its first successes in the fight against cancer with a vaccine. Defence Therapeutics is a Canadian scientific pioneer, uncovering enhanced treatment solutions for future generations through biopharmaceutical innovations. The company specialises in targeting active ingredients, such as vaccines or drugs, by using antibodies that “piggyback” on HOPE OF ALTERNATIVE TREATMENT FOR OSIMERTINIB-RELAPSED 1 day ago · A combination treatment has proved effective in treating patients with lung cancer whose disease progressed after treatment with osimertinib. The Janssen Pharmaceutical Companies of Johnson & Johnson has announced updated data from the Phase 1 CHRYSALIS study. The data shows that treatment with amivantamab in combination with lazertinib led to a median duration of response STUDY DEMONSTRATES LONG-LASTING EFFICACY OF COVID-19 Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks. Biotechnology company Defence Therapeutics Inc specialises in the development of ADCs and therapeutics for cancer and infectious diseases. The organisation MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
CUTTING THE FUEL SUPPLY TO CELLS CAN PREVENT CANCER SPREADING Halting the energy supply to certain cells can help to stop the spread of cancer, researchers have discovered. A study by scientists from the Translational Medicine Laboratory at the University of Salford has discovered that cancer spreading cells are the ‘fittest’ and therefore cutting off their fuel supply can effectively prevent thespread of cancer.
2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
LANDMARK STUDY IDENTIFIES CELLULAR CULPRIT FOR TYPE 1 DIABETES A landmark study has mapped the genetic underpinning for Type 1 diabetes, enabling the identification of a predictive causal role for specific cell types in Type 1 diabetes. Researchers at the University of California San Diego School of Medicine have identified cell type-specific functions of COVID-19 VACCINE RESPONSE DAMPENED BY IBD DRUG INFLIXIMAB A new study has shown that people who take a common drug for inflammatory bowel disease (IBD) have a dampened immune response to the first dose of a COVID-19 vaccine. COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes CAR T-CELL THERAPIES IN EUROPE Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union. In June, the European Medicines Agency (EMA) – the EU agency responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union – recommended that marketing authorisation be granted for the first two chimeric antigen STUDY DEMONSTRATES LONG-LASTING EFFICACY OF COVID-19 Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks. Biotechnology company Defence Therapeutics Inc specialises in the development of ADCs and therapeutics for cancer and infectious diseases. The organisation MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
CUTTING THE FUEL SUPPLY TO CELLS CAN PREVENT CANCER SPREADING Halting the energy supply to certain cells can help to stop the spread of cancer, researchers have discovered. A study by scientists from the Translational Medicine Laboratory at the University of Salford has discovered that cancer spreading cells are the ‘fittest’ and therefore cutting off their fuel supply can effectively prevent thespread of cancer.
2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
LANDMARK STUDY IDENTIFIES CELLULAR CULPRIT FOR TYPE 1 DIABETES A landmark study has mapped the genetic underpinning for Type 1 diabetes, enabling the identification of a predictive causal role for specific cell types in Type 1 diabetes. Researchers at the University of California San Diego School of Medicine have identified cell type-specific functions of COVID-19 VACCINE RESPONSE DAMPENED BY IBD DRUG INFLIXIMAB A new study has shown that people who take a common drug for inflammatory bowel disease (IBD) have a dampened immune response to the first dose of a COVID-19 vaccine. COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes CAR T-CELL THERAPIES IN EUROPE Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union. In June, the European Medicines Agency (EMA) – the EU agency responsible for the scientific evaluation, supervision and safety monitoring of medicines in the European Union – recommended that marketing authorisation be granted for the first two chimeric antigen EU HEALTHCARE & SOCIAL CARE NEWS Health Europa brings you up to the minute news and developments from across the EU Healthcare & Social Care News sector and European (EU) health policy including the latest innovations in health research technology, pharmaceutical news, research into WARMER TEMPERATURES LOWER COVID-19 TRANSMISSION 6 hours ago · Warmer conditions lower the spread of COVID-19 but are not enough alone to prevent transmission, scientists have demonstrated. Researchers at Imperial College London conducted a study incorporating environmental data into epidemiological models of the transmission of SARS-CoV-2, the virus behind COVID-19.. The team concluded that temperature and population density are the most THE IMPORTANCE OF MEDICAL INNOVATION IN THE WAKE OF COVID-19 1 day ago · Andrew Thelwell, Chief Commercial Officer at Sky Medical Technology, outlines why continuing to fast-track innovation after the pandemic is essential. The COVID-19 virus has had a profound impact on global healthcare provision, focusing care on the virus and causing the postponement of many routine SECURING COVID-19 VACCINE CERTIFICATES WITH DISTRIBUTED LEDGER 1 day ago · Alex Fryer at Zebra Technologies discusses global vaccine certification systems combined with the use of distributed ledger technology to improve data security and prevent fraud. Alex Fryer, Intelligent Edge Solutions (IES) Regional Product Manager at Zebra Technologies, discusses the use of STUDY DEMONSTRATES LONG-LASTING EFFICACY OF COVID-19 Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks. Biotechnology company Defence Therapeutics Inc specialises in the development of ADCs and therapeutics for cancer and infectious diseases. The organisation ADVITOS COMPLETES A €20M FINANCING ROUND 3 hours ago · ADVITOS, a medical device manufacturer with a unique therapy for patients with multi-organ failure, has completed a €20m financing round led by Crédit Mutuel Equity, with a co-investment from the EU EIC Fund. IS VACCINE HESITANCY IN AFRICA LINKED TO INSTITUTIONAL 4 hours ago · Dr Jean-François Maystadt, Professor of Economics at Université catholique de Louvain and Lancaster University, discusses institutional mistrust and vaccine hesitancy in Africa. In a report published in the BMJ Global Health journal in April 2021 under the title ‘Institutional mistrust and child NEUROSTEER: ADVANCING EEG INTO THE 21ST CENTURY 5 hours ago · Neurosteer has developed the first ever remote brain activity monitoring, assessment, and neurofeedback platform that will bring the old electroencephalogram (EEG) into the 21st century. Brain health is medicine’s final frontier as the brain is the only organ in the human body which has inadequate ONLINE EXERCISE PROGRAMME COULD PREVENT FALLS IN ELDERLY USERS 1 day ago · The levels of exercise adherence were found higher in interventions led by therapists and in those consisted of moderate home visit support and balance or walking exercise 7. Lifestyle-integrated Functional Exercise (LiFE), a programme complementing individualised exercises with lifestyle FLUENCE EXPANDS IN ISRAELI CANNABIS INDUSTRY WITH LED 8 hours ago · Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced today its implementations with two major cannabis cultivators in Israel – Springs Valley Cannabis LTD and UNIVO Pharmaceuticals (UNIVO). BLOOD OXYGEN LEVELS COULD EXPLAIN MEMORY LOSS IN ALZHEIMER The results of a world-first study that recorded blood oxygen levels could explain why memory loss is a symptom of Alzheimer’s disease. Scientists from the University of Sussex have provided experimental proof for why the area, commonly referred to as ‘the brain’s memory centre’, is vulnerable to damage and degeneration, a precursor to Alzheimer’s disease. MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
COVID-19 GENOMICS UK CONSORTIUM: SEQUENCING COVID-19 The COVID-19 Genomics UK Consortium (COG-UK) was launched in April 2020, with the aim of sequencing the genome of the COVID-19 virus and its variants and providing data to track and analyse viral transmission within the UK. HEQ speaks with COG LANDMARK STUDY IDENTIFIES CELLULAR CULPRIT FOR TYPE 1 DIABETES A landmark study has mapped the genetic underpinning for Type 1 diabetes, enabling the identification of a predictive causal role for specific cell types in Type 1 diabetes. Researchers at the University of California San Diego School of Medicine have identified cell type-specific functions of disease variants, uncovering a predictivecausal
2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
T CELLS KEY TO SEVERITY OF COVID-19 OUTCOMES A new study has suggested that a balanced T cell response to COVID-19 is vital in helping the immune system effectively fight the virus, determining the severity of symptoms in patients. Researchers from Singapore have analysed blood samples of patients with COVID-19 to understand the different responses of T cells to the virus. MODELLING SHOWS HIGH COVID-19 SPREAD WITH RAPID AIR EXCHANGE New modelling has suggested that rapid air exchanges can spread COVID-19 in high concentrations from one room to another. A team of researchers at the US Department of Energy’s Pacific Northwest National Laboratory, including building and heating, ventilation, and air conditioning (HVAC) experts, as well as experts in aerosol particles and viral materials, have used modelling to COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. A new study, carried out by researchers at MIT ‘s Department of Mechanical Engineering, has suggested that coronaviruses may be vulnerable toultrasound
PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections. Immunocompromised patients with HSV often have a chronic form of the virus which is resistant to any anti-viral medication, including acyclovir. BLOOD OXYGEN LEVELS COULD EXPLAIN MEMORY LOSS IN ALZHEIMER The results of a world-first study that recorded blood oxygen levels could explain why memory loss is a symptom of Alzheimer’s disease. Scientists from the University of Sussex have provided experimental proof for why the area, commonly referred to as ‘the brain’s memory centre’, is vulnerable to damage and degeneration, a precursor to Alzheimer’s disease. MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition CONFIRMATION OF STRONG LINK BETWEEN HORMONES AND COVID-19 The European Society of Endocrinology (ESE) has provided a new, expert statement confirming the strong link between hormones and COVID-19. In a new statement, ESE has confirmed that the endocrine system is strongly involved in COVID-19 infections, highlighting that there is now evidence that an “endocrine phenotype” of COVID-19 hasemerged.
COVID-19 GENOMICS UK CONSORTIUM: SEQUENCING COVID-19 The COVID-19 Genomics UK Consortium (COG-UK) was launched in April 2020, with the aim of sequencing the genome of the COVID-19 virus and its variants and providing data to track and analyse viral transmission within the UK. HEQ speaks with COG LANDMARK STUDY IDENTIFIES CELLULAR CULPRIT FOR TYPE 1 DIABETES A landmark study has mapped the genetic underpinning for Type 1 diabetes, enabling the identification of a predictive causal role for specific cell types in Type 1 diabetes. Researchers at the University of California San Diego School of Medicine have identified cell type-specific functions of disease variants, uncovering a predictivecausal
2021: AN OUTLOOK FOR 5G IN HEALTHCARE BT Enterprise Health Sector Lead Lucy Baker explores the role of 5G connectivity in the growing health tech sector. Last year was a year like no other, upending familiar ways of working, lifestyles, cultural norms, and expectations for how we connect and interact with the worldaround us.
T CELLS KEY TO SEVERITY OF COVID-19 OUTCOMES A new study has suggested that a balanced T cell response to COVID-19 is vital in helping the immune system effectively fight the virus, determining the severity of symptoms in patients. Researchers from Singapore have analysed blood samples of patients with COVID-19 to understand the different responses of T cells to the virus. MODELLING SHOWS HIGH COVID-19 SPREAD WITH RAPID AIR EXCHANGE New modelling has suggested that rapid air exchanges can spread COVID-19 in high concentrations from one room to another. A team of researchers at the US Department of Energy’s Pacific Northwest National Laboratory, including building and heating, ventilation, and air conditioning (HVAC) experts, as well as experts in aerosol particles and viral materials, have used modelling to COULD ULTRASOUND FREQUENCIES KILL CORONAVIRUS? New simulations have shown that ultrasound waves at medical imaging frequencies have the potential to kill coronavirus by causing the virus’s shell and spikes to collapse and rupture. A new study, carried out by researchers at MIT ‘s Department of Mechanical Engineering, has suggested that coronaviruses may be vulnerable toultrasound
PRITELIVIR PHASE III CLINICAL TRIALS FOR HSV The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections. Immunocompromised patients with HSV often have a chronic form of the virus which is resistant to any anti-viral medication, including acyclovir. WARMER TEMPERATURES LOWER COVID-19 TRANSMISSION 3 hours ago · Warmer conditions lower the spread of COVID-19 but are not enough alone to prevent transmission, scientists have demonstrated. Researchers at Imperial College London conducted a study incorporating environmental data into epidemiological models of the transmission of SARS-CoV-2, the virus behind COVID-19.. The team concluded that temperature and population density are the most THE IMPORTANCE OF MEDICAL INNOVATION IN THE WAKE OF COVID-19 1 day ago · Andrew Thelwell, Chief Commercial Officer at Sky Medical Technology, outlines why continuing to fast-track innovation after the pandemic is essential. The COVID-19 virus has had a profound impact on global healthcare provision, focusing care on the virus and causing the postponement of many routine SECURING COVID-19 VACCINE CERTIFICATES WITH DISTRIBUTED LEDGER 1 day ago · Alex Fryer at Zebra Technologies discusses global vaccine certification systems combined with the use of distributed ledger technology to improve data security and prevent fraud. Alex Fryer, Intelligent Edge Solutions (IES) Regional Product Manager at Zebra Technologies, discusses the use of NEUROSTEER: ADVANCING EEG INTO THE 21ST CENTURY Neurosteer has developed the first ever remote brain activity monitoring, assessment, and neurofeedback platform that will bring the old electroencephalogram (EEG) into the 21st century. Brain health is medicine’s final frontier as the brain is the only organ in the human body which has inadequate IS VACCINE HESITANCY IN AFRICA LINKED TO INSTITUTIONAL 19 minutes ago · Dr Jean-François Maystadt, Professor of Economics at Université catholique de Louvain and Lancaster University, discusses institutional mistrust and vaccine hesitancy in Africa. In a report published in the BMJ Global Health journal in April 2021 under the title ‘Institutional mistrust and child LOW-COST SENSOR INSOLES CAN DETECT RISK OF DIABETIC FOOT 4 hours ago · A new low-cost method, using 3D-printed structures, has been developed by scientists to help prevent diabetic foot ulcers. Researchers from the Centre for Biomechanics and Rehabilitation Technologies (CRBT) at Staffordshire University have discovered a way to reliably detect the risk of foot ulcers developing, without the need for complex electronic in-shoe sensors. ONLINE EXERCISE PROGRAMME COULD PREVENT FALLS IN ELDERLY USERS 1 day ago · The levels of exercise adherence were found higher in interventions led by therapists and in those consisted of moderate home visit support and balance or walking exercise 7. Lifestyle-integrated Functional Exercise (LiFE), a programme complementing individualised exercises with lifestyle MILD MYOCARDITIS REPORTED WITH COVID-19 MRNA VACCINES Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines. Myocarditis is an inflammation of the heart muscle and pericarditis is an inflammation of the lining that surrounds the heart. The condition can cause serious illness, however, often it is mild and responds well totreatment.
EXPLORING THE EMERGING UK CBD INDUSTRY 1 day ago · In this article, Rick Brar, CEO of Brains Bioceutical, explores the emerging UK CBD industry. The last two years have seen the UK CBD market grow exponentially. Sales of CBD are not just being driven by trendy millennials looking for the next big thing, they are also cutting across a range of demographics and therapeutic applications from chronic pain, anxiety, sport recovery, and general BLOOD OXYGEN LEVELS COULD EXPLAIN MEMORY LOSS IN ALZHEIMER The results of a world-first study that recorded blood oxygen levels could explain why memory loss is a symptom of Alzheimer’s disease. Scientists from the University of Sussex have provided experimental proof for why the area, commonly referred to as ‘the brain’s memory centre’, is vulnerable to damage and degeneration, a precursor to Alzheimer’s disease.__
__ __
__
__
* Home
* News__
* Diseases & Conditions News * Health Policy News * Medical Cannabis News* Pharma News
* Research & Innovation News * Medical Cannabis Network* Partner Profiles
* Special Reports
* Publications__
* Health Europa Quarterly* eBooks
* Subscribe
* About Us__
* Our Management Team* Our Editors
* Our Editorial Board* Testimonials
* Charity Partnership* Sales Approach
__
Search
Wednesday, February 5, 2020* Contact Us
__ __
__
__
* Home
* News__
* Diseases & Conditions News * Health Policy News * Medical Cannabis News* Pharma News
* Research & Innovation News * Medical Cannabis Network* Partner Profiles
* Special Reports
* Publications__
* Health Europa Quarterly* eBooks
* Subscribe
* About Us__
* Our Management Team* Our Editors
* Our Editorial Board* Testimonials
* Charity Partnership* Sales Approach
__ __
Health Europa
Home __ News
__ Research & InnovationNews
__ World Cancer Day 2020: five initiatives to stay optimistic aboutthe future...
* News
* Research & Innovation News WORLD CANCER DAY 2020: FIVE INITIATIVES TO STAY OPTIMISTIC ABOUT THEFUTURE OF CANCER
4th February 2020
iStock/mirrima
THIS WORLD CANCER DAY, EIT HEALTH IS SHOWCASING FIVE GROUNDBREAKING INITIATIVES TO HELP YOU STAY OPTIMISTIC AND HELP TO BEAT CANCER. World Cancer Day aims to save millions of preventable deaths by raising awareness and education about the disease and pushing for collective action. EIT Health , an EU backed network of health innovators showcases five reasons to be optimistic about the fight against cancer. Every nine seconds, there is a new cancer case diagnosed in the EU and it is currently the second leading cause of death following cardiovascular disease. In addition to the considerable impact on the lives of European citizens, cancer puts a huge strain on Europe’s health and social systems as well as the economy. EIT Health plays a huge role in the funding and support of innovations in cancer research and treatment. EIT helps to fight the disease by connecting leading organisations from the worlds of business, research, education and healthcare delivery and providing funding and support to the most promising, cutting-edge solutions. EIT Health CEO Jan-Philipp Beck comments: “Innovation is key to the development of ground-breaking solutions to arm us in the fightagainst cancer.”
This World Cancer Day, EIT has highlighted five ground-breaking initiatives that could help change the future of cancer, including: 1) ARTIFICIAL INTELLIGENCE IS TRANSFORMING DIAGNOSIS The use of AI to diagnose and grade cancers have seen significant advances. Some of these advances have the potential to improve the detection and treatment of the disease. OncoWatch, an EIT Health project, uses an AI system to diagnoseprostate cancer
,
with accuracy that is equivalent to top experts in the field. In a study published in _The Lancet Oncology_,
it was comparable with international, leading uropathologists in determining the Gleason score, the most important prognostic marker for prostate cancer. The OncoWatch, therefore, has the potential to significantly reduce the workload of uropathologists, allowing them to focus on the most difficult cases and at the same time acting as a safety net to improve the standardisation of diagnoses. It also has the potential to speed up prostate cancer diagnostics and reduce the costs for healthcareservices.
A first CE-marked product of OncoWatch is expected to launch in Europe by the end of the year. 2) A PROMISING NEW CANCER THERAPY IS STARTING HUMAN CLINICAL TRIALS The start-up, Peptomyc , supported by EIT Health is leading globally renowned research into an innovative new therapy which has the potential to transform cancer treatment for patients with many different types of cancer. Their research into inhibiting a protein called Myc, which plays an important role in cancer cells’ survival and proliferation, showed that not only was it feasible to inhibit it, but in doing so it has a therapeutic impact against cancer without damaging healthy tissue. Peptomyc is now completing the industrial production of their medicine and is planning to start human clinical trials in patients in 2020. Their research has since paved the way for many more groups around the world who are now developing their own Myc inhibitors. 3) A NEW BLOOD TEST IS IMPROVING THE DETECTION OF PROSTATE CANCER SO THAT IT CAN BE DIAGNOSED EARLIER Stockholm3 , an EIT Health backed project, is a blood test that analyses five protein markers and over 100 genetic markers, along with clinical data, to accurately predict the risk of aggressive prostate cancer, providing an informative indication about whether a biopsy is needed. It is currently used in clinical practice in Sweden, Norway, Finland and Denmark and is in the process of expanding further across Europe and the rest of the world. Stockholm3 could potentially replace or complement the current PSA test,
which can be unreliable, meaning that aggressive forms of prostate cancer can go undetected, thus missing the opportunity for effectiveearly treatment
.
Launching Stockholm3 in more markets provides the opportunity to reduce the number of men unnecessarily undergoing biopsy and treatment and identify aggressive cancers earlier which will help to boost survival rates and reduce healthcare costs. 4) WE ARE USING DATA TO LEARN MORE ABOUT PATIENT RESPONSES TO NEW AND EMERGING IMMUNOTHERAPIESImmunotherapy
is a
revolutionary approach to cancer treatment that helps your immune system fight cancer, but health professionals still don’t understand why some patients respond to it and others do not. The EIT Health-backed project, I4PCM , that brings together several EU cancer care centres to improve the way they share data and thus improve personalised care. The project launched a central database or “Virtual European Cancer Institute” with collective information from the centres about clinical research and patient responses to these new immunotherapies. By unifying efforts to pool information from their clinical, environmental, genomic, imaging and immune biology databases, the data sharing will help to transform clinicians’ and researchers’ approach to cancer research, thereby allowing a deeper understanding of immunotherapy responses than any single centre couldachieve on its own.
5) NEW, NON-INVASIVE TESTS ARE BEING CREATED FOR EARLY INTERVENTION IN THE THIRD MOST COMMON TYPE OF CANCER Colorectal cancer (CRC) is the third most common cancer in men and second most common in women, with 450,000 new patients in Europe annually. Even after successful tumour treatment, 50% of patients will develop colorectalliver metastases
(CRLM), a severe and often fatal condition. COLO-MET are developing a non-invasive and cost-effective urine test, which, combined with the blood test, can specifically detect CRLM, allowing early intervention of colorectal cancer and earliertreatment.
* __
* __
* __
* __
Recommended Related Articles A spotlight on value-based healthcare with Jan-Philipp Beck AI could be set to improve prostate cancer diagnosis and treatment A smart way to ease Europe’s health workforce challenges Blockchain Technology in Healthcare Market value to reach millions by2025
* TAGS
* Cancer
* Cancer Therapy
* digital health
* eHealth
* EIT Health
Becky Brickwood
RELATED ARTICLESMORE FROM AUTHOR EDU-BROTHER: AN INNOVATIVE STUDENT EXCHANGE PROGRAMME PROVIDINGBIOBANK SKILLS
NUI GALWAY LAUNCH €7.45M RESEARCH PROJECT INTO OSTEOARTHRITIS DR GOOGLE: ALMOST HALF OF EMPLOYEES PREFER AN INTERNET DIAGNOSIS SPACE, NEUROGENETICS AND NERVOUS SYSTEM RESEARCH INNOVATION AND EDUCATION IN UROLOGY AT EAU20 EVOLVING THE GERMAN HEALTHCARE SYSTEM WITH DIGITAL APPLICATIONS____
LEAVE A REPLY CANCEL REPLY Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time Icomment.
FOLLOW HEALTH EUROPA* __
* __
* __
SEARCH HEALTH EUROPA HEALTH SPECIAL REPORTS EVERYTHING YOU NEED TO KNOW ABOUT THE ANNUAL MPS THERAPY WEEKSpecial Reports
4th September
2019
MEETING THE CHALLENGES IN UNSCHEDULED CARE DELIVERYSpecial Reports
10th July 2019
SAVING NHS FUNDING: BETTER MEDICATION MANAGEMENT COULD SAVE THE NHSOVER...
Special Reports
12th June 2019
SCIENCE OFF THE BEATEN TRACKSpecial Reports
11th January
2019
HEALTH EBOOKS
THE INSTITUTE FOR CARDIOGENETICS JOINING FORCES TO PROMOTE CARDIOVASCULAR RESEARCH eBooks 19th December2019
HARVESTING NATURE’S HEALING POWER WITH LEAFCANN eBooks 10th December2019
HEALTH PARTNERS
EASY, LOW COST, LEGAL DIGITAL TRANSACTIONSPartner Profiles
10th January
2020
CHAMPIONS OF SELF-HELP SUPPORT AND RESEARCH FOR THERAPYPartner Profiles
1st January
2020
PHARMACOVIGILANCE AND LIFE SCIENCES SERVICES, BROUGHT TO YOU BYPROPHARMA GROUP
Partner Profiles
9th December
2019
PILLTIME: THE DIGITAL PHARMACY USING ROBOTIC TECHNOLOGYPartner Profiles
3rd July 2019
LATEST SPECIAL REPORTS EVERYTHING YOU NEED TO KNOW ABOUT THE ANNUAL MPS THERAPY WEEKSpecial Reports
4th September
2019
MEETING THE CHALLENGES IN UNSCHEDULED CARE DELIVERYSpecial Reports
10th July 2019
SAVING NHS FUNDING: BETTER MEDICATION MANAGEMENT COULD SAVE THE NHSOVER...
Special Reports
12th June 2019
LATEST EBOOKS
THE INSTITUTE FOR CARDIOGENETICS JOINING FORCES TO PROMOTE CARDIOVASCULAR RESEARCH eBooks 19th December2019
HARVESTING NATURE’S HEALING POWER WITH LEAFCANN eBooks 10th December2019
LATEST PUBLICATIONS
HEALTH EUROPA QUARTERLY ISSUE 12 Health Europa Quarterly3rd February 2020
HEALTH EUROPA QUARTERLY ISSUE 11 Health Europa Quarterly11th October 2019
ABOUT USThe Health Europa website exists to provide up to the minute news and developments from across the entire spectrum of EuropeanHealth Policy.
Contact us: info@healtheuropa.euFOLLOW US __ __
__
* Privacy Policy
* Helpsheets
* Terms & Conditions * Feedback & Complaints * Preparing for GDPR * GDPR Privacy Policy Pan European Networks LtdPIN IT ON PINTEREST
UK OFFICE: +44 (0)1260 273 802 2018 - Published by Pan European Networks Ltd in Congleton, United Kingdom. - Co. Reg. No: 7652562 Disclaimer: www.healtheuropa.eu is an independent portal and is not responsible for the content of external sites. Please Note: Phone calls may be recorded for training and monitoringpurposes.
Edit with Live CSS
Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0